CME Group Inc. (CME) vs Schwab U.S. Dividend Equity ETF (SCHD)
Over the past 10 years, CME outperformed SCHD — 14.06% vs 13.11% annualized total return (price plus dividends).
A side-by-side comparison of CME Group Inc. and Schwab U.S. Dividend Equity ETF across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
Total return — CME vs SCHD
growth of $100 · dividends reinvested · last 10yMetrics side by side
Did CME beat SCHD?
Over the past 10 years, CME outperformed SCHD — 14.06% vs 13.11% annualized total return (price plus dividends).
Total return (annualized)
| Metric | CME | SCHD |
|---|---|---|
| Total return (1Y) | 6.54% | 28.75% |
| Total return CAGR (3Y) | 14.09% | 15.72% |
| Total return CAGR (5Y) | 11.89% | 9.87% |
| Total return CAGR (10Y) | 14.06% | 13.11% |
SCHD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has CME beaten SCHD?
- Over the past 10 years, CME outperformed SCHD — 14.06% vs 13.11% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.